BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-6 out of 6 found
  Current Search:  sinusitis: 6     

HTML
100%
Sinusitis a leading culprit in pediatric toxic shock syndrome
MedWire News: Rhinosinusitis is a leading cause of toxic shock syndrome (TSS) in children, research shows.

Based on a retrospective case review, Kenny Chan from University of Colorado in Denver, USA, and colleagues say that rhinosinusitis...

MedWire News:  Jun 18 2009 10:35PM
Matching: sinusitis
Find similar documents
HTML
100%
Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
The oral poster presentation, Effects of Denufosol on Sinusitis-related Complaints in a Phase 3 Trial in Cystic Fibrosis Patients (A.R.

Mospan, T.A.

Durham, A.E.

Schaberg, F.J.

Accurso), occurs during Oral Poster Session II -...

Pharma Live:  Jun 12 2009 6:11PM
Matching: sinusitis
Find similar documents
HTML
100%
Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
News source: Business Wire Inspire Pharmaceuticals, Inc.

(NASDAQ:ISPH) announced today Inspire scientists and collaborators are presenting additional data from TIGER-1, the Companys first Phase 3 trial with denufosol tetrasodium for the...

Genetic Engineering News:  Jun 12 2009 12:57PM
Matching: sinusitis
Find similar documents
HTML
100%
Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
- Inspire Pharmaceuticals, Inc.

(NASDAQ:ISPH) announced today Inspire scientists and collaborators are presenting additional data from TIGER-1, the Companys first Phase 3 trial with denufosol tetrasodium for the treatment of cystic...

DiGiTAL50:  Jun 12 2009 12:44PM
Matching: sinusitis
Find similar documents
HTML
100%
Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
DURHAM, N.C.

- (BUSINESS WIRE) - Inspire Pharmaceuticals, Inc.

(NASDAQ:ISPH) announced today Inspire scientists and collaborators are presenting additional data from TIGER-1, the Company's first Phase 3 trial with denufosol tetrasodium...

NewsBlaze:  Jun 12 2009 12:39PM
Matching: sinusitis
Find similar documents
HTML
100%
Inspire Announces Presentations at European Cystic Fibrosis Society Annual Meeting
Inspire Pharmaceuticals, Inc.

(NASDAQ:ISPH) announced today Inspire scientists and collaborators are presenting additional data from TIGER-1, the Companys first Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis,...

Genetic Engineering News:  Jun 12 2009 12:17PM
Matching: sinusitis
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.